Summary of ongoing reslizumab studies in patients with eosinophilic asthma. | Download Table
Cinqair (reslizumab): Basics, Side Effects & Reviews
Clinical Outcomes and Health-Care Resource Use Associated With Reslizumab Treatment in Adults With Severe Eosinophilic Asthma in Real-World Practice - CHEST
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
CINQAIR® (reslizumab) Injection – About Asthma Control
Teva's Asthma Therapy Reslizumab Fails in Late-Stage Studies
New Severe Asthma Rx Gets Green Light | RxWiki
Teva's severe eosinophilic asthma drug Cinqaero wins EU approval
Teva's Asthma Segment: What Could Boost Its Revenues in 2016?
NICE changes mind and backs new drug for severe asthma | Nursing Times
Subcutaneous Cinqair results add to Teva's troubles
cinqaero - Twitter Search / Twitter
Rx Item-Cinqair (Reslizumab) 10Mg/Ml Inj Sinle Use Vial 10Ml By Teva Respiratory
A Guide to the PRESCRIPTION AND SERVICE REQUEST FORM FOR CINQAIR® ( reslizumab) Injection
Teva files MAA for asthma treatment reslizumab
CADTH CANADIAN DRUG EXPERT COMMITTEE FINAL RECOMMENDATION
BUY Reslizumab (CINQAIR) 10 mg/mL Teva Respiratory, LLC
Teva Announces EMA Validation of Reslizumab Marketing Authorization Application
Reslizumab – All About Drugs
A Guide to the Prescription and Service Request Form
Teva announces FDA approval for asthma injection, Cinqair | Pharmafile
Israeli Pharma gets FDA Approval for Asthma Antibody
NICE Recommends CINQAERO (reslizumab) for the Treatment of Severe Eosinophilic Asthma » FINCHANNEL
Brand name: Auvi-Q
Chest Medicine Made Easy-Dr Deepu: FDA approves Injectable drug for uncontrolled Asthma
Upcoming Reslizumab PDUFA- Approval Odds, And What It Means For Teva (NYSE: TEVA) | Seeking Alpha
Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands – An evaluation - Respiratory Medicine
Injectable asthma drug reslizumab approved by European Commission - The Pharmaceutical Journal
